Lanxess´s New Facility: Standards for Sustainable Production Lanxess Opens Ion Exchanger Facility in India and Looks for Expansion

High growth rates coupled with attractive relocation packages are the best incentives for enticing international chemicals companies to develop production sites in India. Lanxess is responding to the invitation with significant investment. The latest step is the opening of an ultramodern plant for ion exchangers in Jhagadia.

Related Vendors

Glatt Ingenieurtechnik GmbH

Maag Pump Systems AG

ProMinent GmbH

The Indian subcontinent is booming with economic activity and many global chemicals giants want to participate in this growth. For specialty-chemical manufacturer Lanxess, India has already become the second-strongest growth market in Asia. In light of favorable growth prospects, Lanxess group CEO, Axel C Heitmann, recently decided to step-up the pace of expansion there even further in the next five years.

Modern facility in Jhagadia

Since Lanxess announced the acquisition of listed Indian company Gwalior Chemical Industries Ltd in June 2009, the group, which is based in Leverkusen, Germany, has been firmly on the road to expansion. Headed by German manager Dr Jörg Straßburger, production is already underway at three Indian sites: Nagda (Madhya Pradesh), Madurai (Tamil Nadu) and Jhagadia (Gujarat). The latest high point was the opening of the Jhagadia plant in early December last year. With a capacity of 35,000 mt, the plant boasts of one of the most modern ion exchanger facilities in Asia. Previously, in May 2008, the company had stopped production at its business unit Ion Exchange Resins in Birmingham, New Jersey, USA, with the argument that the limited production capacities there rendered the plant ill-suited to the fast-changing ion exchanger market of the future. The USA site was run by the fully-owned subsidiary Lanxess Sybron Chemicals. Now some 200 workers at the Jhagadia chemical park are manufacturing products for industrial-water treatment for the semiconductor and pharmaceuticals industry, and for the food and energy sectors throughout Asia.

(ID:25800540)